Seeking consent

OTHER2 trials

Sponsors

The Wellcome Sanger Institute

Conditions

CancerSomatic Mutation

Unknown Phase

SMS 2: Impact of Cancer Therapy on the Somatic Mutational Landscape of Normal Tissues

Enrolling by invitationNCT06832150

The Wellcome Sanger InstituteCancer, Somatic Mutation

Start: 2024-11-26End: 2029-05-13Target: 60Updated: 2025-02-18

SMS - Study of Somatic Mutations Using Genome Sequencing

Enrolling by invitationNCT06851052

The Wellcome Sanger InstituteSomatic Mutation

Start: 2016-10-01End: 2028-07-14Target: 600Updated: 2025-07-20